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Abstract. Potential interactions between membrane
components of rat brain synaptic vesicles were ana-
lyzed by detergent solubilization followed by size frac-
tionation or immunoprecipitation . The behavior of six
synaptic vesicle membrane proteins as well as a plasma
membrane protein was monitored by Western blotting.
Solubilization of synaptic vesicle membranes in CHAPS
resulted in the recovery of a large protein complex
that included SV2, p65, p38, vesicle-associated mem-
brane protein, and the vacuolar proton pump. Solubili-
zation in octylglucoside resulted in the preservation of
interactions between SV2, p38, and rab3A, while
solubilization of synaptic vesicles with Triton X-100
resulted in two predominant interactions, one involving
p65 and SV2, and the other involving p38 and vesicle-
YNAPTIC transmission is the primary basis of inter-
cellular communication within the nervous system.
Central to this process are the synaptic vesicles respon
sible for the storage and exocytotic release ofneurotransmit-
ter. The life cycle of a synaptic vesicle includes steps of bio-
genesis, exocytosis, and membrane recycling (for reviews
see Kelly, 1988 ; Sudhof and Jahn, 1991; Trimble et al.,
1991) . Synaptic vesicle components are synthesized in the
cell body and transported down the axon to the presynaptic
nerve terminal. Within the terminal, the vesicles are loaded
with neurotransmitter and stored either adjacent to the pre-
synaptic plasma membrane at the active zone, or in clusters
associated with cytoskeletal elements. Stimulation of the
nerve terminal results in calcium influx which effects fusion
of the synaptic vesicles with the plasma membrane. After
exocytosis, synaptic vesicle membrane components are se-
lectively recovered from the presynaptic plasma membrane
by endocytosis and are recycled within the nerve terminal
into mature synaptic vesicles. A molecular description of
these membrane trafficking events and their physiological
regulation is required for a more detailed understanding of
synaptic transmission .
One approach toward understanding the molecular mecha-
nisms involved in synaptic transmission has been to identify
and characterize the components of the synaptic vesicle
membrane. A number of proteins are localized to synaptic
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associated membrane protein . The multicomponent
complex preserved with CHAPS solubilization was
partially reconstituted following octylglucoside
solubilization and subsequent dialysis against CHAPS.
Reduction of the CHAPS concentration by gel filtra-
tion chromatography resulted in increased recovery of
the multicomponent complex . Examination of the large
complex isolated from CHAPS-solubilized vesicles by
negative stain EM revealed structures with multiple
globular domains, some of which were specifically la-
beled with gold-conjugated antibodies directed against
p65 and SV2 . The protein interactions defined in this
report are likely to underlie aspects of neurotransmit-
ter secretion, membrane traffic, and the spatial organi-
zation of vesicles within the nerve terminal.
vesicles, including SV2 (Buckley and Kelly, 1985), p65
(synaptotagmin; Matthew et al ., 1981), p38 (synaptophysin;
Wiedenmann and Franke, 1985; Jahn et al., 1985), vesicle-
associated membrane protein (VAMP)' (synaptobrevin;
Trimble et al., 1988; Baumert et al., 1989), rab3A (smg25A;
Matsui et al., 1988; Zahraoui et al., 1989; Fischer von Mol-
lard et al., 1990; Volknandt et al., 1991), the vacuolar proton
pump (Chidon and Shira, 1989; Yamagata and Parsons,
1989; Floor et al., 1990), synapsins I and H (DeCamilli et
al ., 1983 ; Sudhof et al., 1989a), a high molecular weight
proteoglycan (Stadler and Dowe, 1982; Carlson and Kelly,
1983), VAT-I (Linial et al., 1989), and p29 (Baumert et al .,
1990) . Many of these proteins are evolutionarily conserved
and are localized to vesicle populations containing different
classes of neurotransmitter, suggesting that they play a fun-
damental role in the targetting, fusion, and recycling of syn-
aptic vesicle membranes. An understanding of the functions
of these proteins requires both determination of the proper-
ties ofeach protein individually, and characterization oftheir
interactions with other proteins. The isolation of cDNA
clones encoding several synaptic vesicle membrane proteins
has greatly increased our knowledge about the individual
proteins and has suggested possible functions (see Sudhof
l. Abbreviation used in this paper: VAMP, vesicle-associated membrane
protein.
761and Jahn, 1991) . However, very little isknown about interac-
tions that involve these proteins .
The present study was undertaken to identify and char-
acterize the potential interactions among some ofthe known
synaptic vesicle proteins. We have concentrated our analysis
on the sixmembrane proteins diagrammed in Fig. 1 and de-
scribed below . (a)SV2 (75-150 kD) is a glycosylated integral
membrane protein recognized by amAb (Buckley and Kelly,
1985) with an as yetunknown structure or function . (b) p65
(65 kD) is an abundant synaptic vesicle protein with a single
transmembrane domain, a N11 2-terminal intravesicular do-
main, and a cytoplasmic domain containing two repeats ho-
mologous to the regulatory domain of protein kinaseC (Pe-
rin et al ., 1990 ; Wendland et al., 1991) . This protein binds
phospholipids, has hemagglutination activity, and has re-
cently been shown to exist in a multimeric complex (Perin
et al ., 1990, 1991) . It has been proposed that p65 plays a role
in the docking and/or fusion of synaptic vesicles with the
plasma membrane. (c) p38 (40 kD) is an abundant vesicle
glycoprotein that has four transmembrane domains (Buckley
et al., 1987 ; Leube et al., 1987; Siidhof et al ., 1987 ; Cowan
et al ., 1990), binds Cal+ (Rehm et al., 1986), and has the
capacity to form homooligomeric structures that can gener-
ate channels in artificial bilayers (Rehm et al ., 1986 ; Thomas
et al., 1988 ; Johnston and Südhof, 1990) . It has been pro-
posed that p38 might function in the formation of fusion
pores during exocytosis . (d) VAMP is an 18-kD protein an-
chored to the synaptic vesicle membrane by a 000H-
terminal hydrophobic domain (Trimble et al ., 1988 ; Südhof
et al., 1989b) . The function of VAMP is unknown, but re-
cently several proteins with domain structures similar to
VAMP have been identified in yeast (Dascher et al ., 1991 ;
Shim et al., 1991) . These proteins have been shown in
genetic studies to interact with a number ofproteins required
for a functional secretory pathway, including the low molec-
ular weight GTP-binding protein YPTI . (e) rab3A (25 kD)
is a member of a family of low molecular weight GTR
binding proteins that have been implicated in the regulation
of intracellular membrane traffic (Zahraoui et al ., 1989 ;
Salminen and Novick, 1988 ; Segev et al ., 1988 ; Chavrier et
al ., 1990 ; Gorvel et al ., 1991) . As with other low molecular
weight GTP-binding proteins, rab3A is likely to be localized
to membranes, at least in part, by a COOH-terminal isopre-
noid group (Hancock et al., 1989 ; Johnston, et al., 1991) .
(f)The vacuolar protonpump is a large multimeric complex
(500 kD) made up of at least seven subunits (Nelson, 1989 ;
Stone et al ., 1989) . Subunits A and B form the catalytic
ATP-binding domain of the pump, while subunit c is a pro-
teolipid that forms the proton-conducting pore . The proton
pump is localized to a variety of intracellular organelles
where it functions in the acidification of lumenal compart-
ments. In synaptic vesicles, the proton gradient is used to
drive the uptake of neurotransmitters (Chidon and Shira,
1989 ; Yamagata and Parsons, 1989 ; Maycox et al ., 1990) .
We have used detergent solubilization of rat brain synaptic
vesicles followed by size fractionation or immunoprecipita-
tion to analyze the interactions between these synaptic vesi-
clemembrane proteins . The distribution of each of the vesi-
cle proteins was evaluated by Western blotting . In the case
of the vacuolar proton pump, the 39-kD accessory protein
(H+ 39 kD) was monitored. We have found that a large com-
plex including five ofthe six vesicle proteins is preferentially
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Figure 1. Synaptic vesicle membrane proteins . A schematic repre-
sentation of the synaptic vesicle membrane proteins analyzed in the
present study. The structure and subunit nomenclature of the vacuo-
lar proton pump is adapted from Nelson (1989) .
preserved following solubilization in CHAPS . In addition,
interactions involving subgroups of the vesicle proteins are
detected following solubilization in octylglucoside or Triton
X-100. These interactions may reflect functional associations
of the synaptic vesicle proteins involved in the biogenesis,
exocytosis, or recycling of synaptic vesicles .
Materials andMethods
Materials
Electrophoresis-grade reagents, gelatin, Triton X-100, and Bio-Gel A-5m
column resin were purchased from Bio-Rad Laboratories (Richmond, CA) .
CHAPS, octylglucoside, and mAb SY38 (anti-p38 ; Weidenmann and
Franke, 1985) were obtained from Boehringer-Mannheim Biochemicals
(Indianapolis, IN) . Anti-mouse IgG, BSA, lipid standards, and reagent
grade chemicals were obtained from SigmaChemical Co. (St . Louis, MO) .
125I-labeled anti-mouseand anti-rabbitIgG wereobtained fromICN Radio-
chemicals (Irvine, CA) . Prestained PAGE molecular weight standards were
purchased from Bethesda Research Laboratories (Gaithersburg, MD) and
proteinASepharose was obtained from Pharmacia LKB Biotechnology
(Piscataway, NJ) . All centrifuge rotors were from Beckman Instruments
(Palo Alto, CA) . The following sources of antibodies are gratefully ac-
knowledged . mAb 10113 (anti-SV2 ; Buckley andKelly, 1985) was provided
by Dr. Regis Kelly (University of California, San Francisco, CA) . mAb
M48 (anti-p65 ; Matthew et al ., 1981) was provided by Dr. Louis Reichardt
(University ofCalifornia, SanFrancisco, CA) . Affinity purified ascites fluid
for both anti-SV2 and anti-p65 were prepared by Berkeley Antibody Co .
(Richmond, CA) . Rabbit polyclonal antibodies generated against the 115-
and 39-kD accessory proteins of the vacuolar proton pump (Moriyama and
Nelson, 1989) were kindly provided by Dr. Nathan Nelson (Roche Institute
of Molecular Biology, Nutley, NJ) .A rabbit polyclonal antibody generated
762against the a subunit of the Na+1K+ ATPase was provided by Dr. James
Nelson (Stanford University, Stanford, CA). Antibodies provided by mem-
bers of this laboratory were rabbit polyclonal antisera generated against a
VAMP fusion protein (Trimble et al., 1990) and against a synthetic peptide
corresponding to the conserved hydrophilic domain of VAMP I (peptide B)
by Dr. William Trimble, an affinity purified rabbit polyclonal antibody
generated against a COON-terminal peptide ofrab3A by Dr. Lisa Elferink
(Stanford University), and mAb 6172 (hybridoma culture supernatant)
directed against Aplysia atrial gland dense core granules prepared by Dr.
Wayne Sossin (Stanford University) .
Synaptic VesiclePreparation
A synaptic vesicle fraction was prepared by a modification of the procedure
described by Huttner et al. (1983). All procedures were carried out at 4°C
with ice-cold buffers. Brains from 150 g male Sprague Dawley rats were
homogenized in 0.32 M sucrose, 10 mM Hepes-KOH (pH 7.5), 1 mM
EGTA, 0.1 mM EDTA, 0.3 mM PMSF (10 ml/brain) by eight up-and-down
strokes with a Teflon/glass homogenizer. A postnuclear supernatant was
prepared by centrifugation of the homogenate at 2,500 rpm (1,000 g) for
10 min in a JS-13 rotor. A synaptosomal pellet was obtained by centrifuga-
tion of the postnuclear supernatant at 12,500 rpm (25,000 g) for 13 min in
the same rotor. The synaptosomal pellet was washed once by resuspension
in Hepes-buffered saline (142 mM NaCl, 2.4 rnM KCI, 1 MM MgC12, 5
MM D-glucose, 0.1 mM EGTA, 10 mM Hepes-KOH (pH 7.5), 0.3 mM
PMSF; 8 ml/brain) and recentrifugation, resuspended in Hepes-buffered sa-
line (1.6 nil/brain), and then lysed by dilution into 10 volumes of H2O. The
lysis and release ofsynaptic vesicles was promoted by homogenization with
a Teflon/glass homogenizer (five up-and-down strokes) and incubation on
ice for 30 min. Large membrane fragments were removed by centrifugation
at 15,000 rpm (42,000 g) for 16 min in an SW28 rotor and synaptic vesicles
(and small membrane fragments) were recovered by centrifugation of the
resulting supernatant at 28,000 rpm (141,000 g) for 4 h in an SW28 rotor.
The resulting pellet (LP2) was used as a crude synaptic vesicle fraction or,
in some cases, purified further by size exclusion chromatography on a con-
trolled pore glass bead column.
Sucrose Gradient Sedimentation
An LP2 fraction prepared from five brains was resuspended in 4.5 nil HKA
buffer (10 mM Hepes-KOH (pH 7.5), 140 mM potassium acetate, 1 mM
MgC12, 0.1 mM EGTA), and divided into nine 250-1a1 fractions (0.5 mg
protein each) . The fractions were solubilized by addition ofan equal volume
of one ofthree detergent solutions (4% CHAPS, 8 % octylglucoside, or 4%
Triton X-100 prepared in HKA buffer; three fractions with each detergent)
followed by end-over-end mixing at 4°C for 1 h. Insoluble material was re-
moved by centrifugation at 15,000 rpm (18,500 g) for 15 min in a refriger-
ated microfuge. Greater than 90% of the synaptic vesicle markers were re-
covered in the supernatant under all three solubilization conditions (not
shown). The solubilized vesicle fractions were layered onto nine 4.5-ml lin-
ear 5-20% sucrose gradients (prepared in HKA buffer containing 1%
CHAPS, 1% octylglucoside, or 0.1% Triton X-100; three gradients with
each detergent) in SW55 centrifuge tubes and subjected to centrifugation
at 50,000 rpm (300,000 g) for 1.5, 5, or 16 h (one gradient of each detergent
for each time). 10 0.5-ml fractions were collected starting from the top of
each gradient with an Auto Densi-flow IIC gradient fractionator (Buchler
Instruments, Lenexa, KS). The protein in each fraction was concentrated
by TCA precipitation and solubilized in 100 Al SDS gel sample buffer. The
pellets in the SW55 tubes following gradient fractionation were solubilized
directly in 100 Al SDS gel sample buffer.
Immunoprecipitations
Five samples of protein A-Sepharose (50 Al packed beads) were each sus-
pended in 1 nil HKA buffer containing 0.1% gelatin and 0.1% BSA and the
following antibody preparations added: (a) 80 Al hybridoma 6172 culture su-
pernatant (b) 4 Al anti-p65 ascites fluid; (c) 50 Al anti-SV2 affinity purified
ascites fluid (0.78 mg/ml); (d) 10 Al rabbit anti-mouse IgG (2.2 mg/ml);
and (e) 20 Al antiVAMP (fusion protein) polyclonal serum. The anti-
body/bead mixture was incubated with end-over-end mixing for 2 h at 4°C
and then washed three times with HKA buffer containing 0.1% gelatin. Af-
ter the last wash, each sample was divided into four equal aliquots equiva-
lent to 12.5 Al packed beads. Solubilized vesicle samples (prepared as de-
scribed below) were added to three of the bead samples and the fourth was
solubilized directly in 60 Al SDS sample buffer. While the antibodies were
binding to the protein A-Sepharose, an LP2 fraction prepared from five
Bennett et al. Synaptic Vesicle Protein Complex
brains was resuspended in 10 nil HKA buffer (1 mg of protein/ml) and
divided intothree 2 .5-ml aliquots. The samples were solubilized by addition
ofCHAPS, octylglucoside, or Triton X-100 to final concentrations of 2, 4,
and 2%, respectively, followed by end-over-end mixing for 1 h at 4°C. In-
soluble material was removed by centrifugation (18,500 g for 15 min) and
gelatin and BSA were each added to a concentration of 0.1%. Four 500 Al
aliquots of the solubilized vesicles were added to the antibody/protein
ASepharose complexes prepared as described above (bead samples a, b,
c, and e). A fifth 500-Al aliquot of the solubilized vesicles was incubated
with 1.5 wg anti-p38 for 2 h beforeaddition tobead samples d. Binding was
allowed to occur for 2 h at 4°C with end-over-end mixing after which time
the beads were recovered by brief centrifugation in a microfuge. The beads
were washed three times with 1 ml HKA buffer containing 0.1% gelatin and
2% detergent (the sameas was used for solubilization). Immunoprecipitated
proteins were recovered by addition of 60 Al SDS gel sample buffer to each
sample of beads.
LipidAnalysis
Lipid extractions were performed on LP2 (100 Al, 2 mg protein/ml), intact
vesicles immunoprecipitated with anti-p65 from 1 ml 0.5 M NaCl-treated
LP2, and the multimeric complex immunoprecipitated with anti-p65 from
1 ml CHAPS-solubilized LP2. Each sample was mixed with 600 Al
CHC13:methanol:HCl (2/1/0.02) followed by 400 Al methanol :0.2 M KCl
(1/1) and the phases separated by brief centrifugation in a microfuge. The
organic phase was collected, dried under N2, and resuspended in 20 Al
CHC13:methanol (95/5). The extracted lipids were spotted on silica gel 60
TLC plates (Merck, Darmstadt, Germany), developed in CHCI3:metha-
nol:acetic acid (65/15/10), and detected with 10% CuSO4/8% H3PO4 and
baking at 180°C for 10 min (Yso andPoduslo, 1988). The proteinremaining
in the interface and aqueous phase following extraction was recovered by
TCA precipitation and suspended in 100 Al SDS gel sample buffer.
Reconstitutionofthe VesicleProtein Complex
A 2-ml sample of LP2 (1 mg of protein/ml in HKA buffer) was solubilized
by addition ofoctylglucoside to a concentration of4% and mixing for 1 h.
The octylglucoside was exchanged for CHAPS by dialysis against 250 nil
HKA buffer containing 0.5% CHAPS for 13 h with one change of buffer.
The dialysate was brought to a concentration of 2 % CHAPS and insoluble
material removed by centrifugation (18,500 g for 15 min). 1/2-ml aliquots
were used for immunoprecipitation with control beads (6172) or anti-p65
beads as described above.
GelFiltration Chromatography
A 0.5-nil sample of LP2 (2 mg protein/ml in HKA buffer) was solubilized
by addition of 0.5 ml HKA buffer containing 4% CHAPS followed by end-
over-end mixing for 1 h. Insoluble material was removed by centrifugation
(18,500 g for 15 min) and the resulting supernatant was loaded onto a 1.0
x 49 cm Bio-Gel A-5m column equilibrated with HKA buffer containing
1% CHAPS. 1-ml fractions were collected and proteins recovered by TCA
precipitation (total protein) or immunoprecipitation (proteincomplexes) as
described in the text. In a separate experiment, an LP2 fraction from 10
brains was further enriched by controlled pore glass bead chromatography.
The included vesicle peak fractions were pooled, concentrated by ultracen-
trifugation, and solubilized in 4.5 nil HKA containing 2 % CHAPS (0.22
mg protein/ml). After removal of insoluble material, the sample was loaded
onto a 2.5 x 50 cm Bio-Gel A-5m column equilibrated with HKA buffer
containing 0.25% CHAPS. 5-ml fractions were collected and the proteins
from 0.5-ml aliquots of each were concentrated by TCA precipitation.
Preparation ofAnti-p65 andAnti-SV7
GoldConjugates
8-nm colloidal gold was prepared using a modification of the method of
Muhlpfordt (1982). Briefly, 1 ml of 1% HAuC14 was added to 99 nil dis-
tilled, deionized H2O in a 500 ml acid-cleaned Erlenmeyer flask, brought
to a slow boil, and boiled for 5 min. A premixed sterile filtered solution
of2.0 ml 1% sodium citrate and 0.50 nil 1% tannic acid was added rapidly
with swirling, and the mixture boiled for 30 min. The gold sol was cooled
and stored for 1 wk at 4°C in 50-ml conicaltubes. Affinity purified anti-p65
(1.5 mg/ml) was dialyzed overnight against 0.1 M sodium borate, pH 8.6,
with three changes of buffer. The colloidal gold sol was titrated against the
dialyzedantibody; 47.5 nil ofthe sol were stabilized with 210 Al ofantibody.
BSA wasadded to a finalconcentration of0.25% from a sterile, filtered 10%
763stock solution. 50 ml Auro-beads (20 nm; Amersham, Arlington Heights,
IL) were coupled to 380 ul affinity purified anti-SV2 (0.78 mg/ml) essen-
tially as described above. The gold-conjugated antibodies were subjected
to centrifugation for 75 min at 20,000 rpm (70,000 g) in an SW28 rotor.
The soft pellets were recovered and dialyzed overnight in PBS/glycerol (1/1),
and thereafter stored at -20°C.
Negative Staining
Four aliquots of synaptic vesicles (isolated by control pore glass bead chro-
matography; 1 mg protein) were each solubilized in 1 ml HKA buffer con-
taining 2 % CHAPS for 1 h at 4°C followed by removal ofinsoluble material
by centrifugation (18,500 g for 15 min). The first sample (a) was directly
loaded onto a 1.0 x 49 cm BioGel A-5m gel filtration column equilibrated
with HKA buffer containing 1% CHAPS. The second sample (b) was in-
cubated with 1014 gold-conjugated anti-p65 for 2 h at 4°C before loading
onto the gel filtration column. The third sample (c) was incubated with 5
Al gold-conjugated anti-SV2 and 10 pl gold-conjugated anti-p65 for 2 h at
4°C before loading onto the gel filtration column. The final sample (d) was
incubated with 10014 affinity purified anti-p65 (1.5 mg/ml) for 30 min be-
fore addition of 10 k1 of gold-conjugated anti-p65. The incubation was con-
tinued for 1.5 h at which time the mixture was loaded onto the gel filtration
column. Fractions 18, 19, and 20 corresponding to the elution position of
the multicomponent complex (see Results) were pooled. Aliquots (50 ul)
ofpooled fractions were fixed by adding an equal volume of2 x fixative con-
sisting of 4% glutaraldehyde, 2% paraformaldehyde, 2% acrolein, and 2
mM CaC12 in 0.1 M sodium cacodylate buffer, pH 7.2 Glow-discharged
formvar-coated 75 mesh nickel grids were floated on dropletsofthe sample-
fixative mixture for 30 min, and then briefly washed in distilled, deionized
H2O. The grids were then stained for 20-40 s in 2% aqueous uranyl ace-
tate, pH 3.7, and excess stain removed with filter paper (Hayat, 1989). After
drying, the grids were examined at 80 kV in a Philips 410 TEM, equipped
with a LaB6 filament.
Western Blotting
Proteins resolved by SDS-PAGE were electrophoretically transferred to
nitrocellulose in 384 mM glycine, 50 mM Tris-base, and 20% methanol
(Towbin et al., 1979). The nitrocellulose filters were incubated with block-
ing buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% BSA, 0.5 % Tween
20) for 30 min and then cut into horizontal strips based on the migration
of prestained molecular weight markers flanking the samples to be ana-
lyzed. The region of the blot from the 68-kD marker to the top was probed
with either anti-SV2 (1:1,000), anti-Na/K ATPase (1:1,000), or antibody to
the 115-kD accessory protein ofthe proton pump (1:200). The region of the
blot between 43 and 68 kD was probed with anti-p65 (1:20,000). The strip
between 29 and 43 kD was probed witheitheranti-p38 (50 ng/ml) or anti-H+
39 kD (1:200). The region ofthe blotbetween 18 and 29 kD wasprobedwith
anti-rab3A (1:100), and that between 14 and 25 kD was probed with anti-
VAMP (anti-peptide B, 1:1,000). Incubation with the primary antibody was
carried out for 2 to 16 h. The blots were washed three times for 5 min with
blocking buffer and then incubated with 1211-labeled anti-mouse or
anti-rabbitsecondary (1-21iCi/ml inblocking buffer) for 2 h. Theblots were
again washed three times for 5 mineach, blotted dry, and exposed to XAR-5
filminthepresenceofan intensifying screen. Exposure times variedbetween
2hand2d.
Other Methods
Proteins were concentrated for PAGE by addition ofTUA to a final concen-
tration of20% . The TCA-precipitated protein was recovered by centrifuga-
tion at 15,000 rpm (18,500 g) for 10 min in a refrigerated microfuge, washed
once with ice cold acetone to remove excess TCA, and solubilized in SDS
sample buffer. SDS-PAGE was performed by the method of Laemmli
(1970). The stacking gel (10 x 90 x 1.5 mm) contained 4.8% acryl-
amide/0.2% bisacrylamide and the resolving gel (55 x 90 x 1.5 mm) con-
tained 12% acrylamide/0.2% bisacrylamide. SDS-PAGE sample volumes
were 20111. Silver staining ofSDS gels was carried out asdescribed by Heu-
keshoven and Dernick (1985). Protein concentrations were determined by
the BCA assay (Pierce, Rockford, IL; Smith et al., 1985). Quantitation of
stained gels and autoradiograms was performed with a computing den-
sitometer(Molecular Dynamics, Sunnyvale, CA). The stoichiometry ofthe
synaptic vesicle proteins was determined by dividing the integrated
Coomassie blue staining intensity of each protein by its relative molecular
weight. The resulting value was divided by the corresponding value for p65
to obtain a molar ratio relative to p65.
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Results
Sucrose Gradient Sedimentation
Potential interactions involving synaptic vesicle membrane
proteins were analyzed by detergent solubilization and sub-
sequent velocity sedimentation on sucrose density gradients.
A synaptic vesicle fraction prepared from rat brain was solu-
bilized in one of three detergents. The three detergents, one
zwitterionic (CHAPS) and two nonionic (octylglucoside and
Triton X-100), were chosen because of their nondenaturing
properties and abilities to preserve functional membrane
protein complexes (Hjelmeland and Chrambach, 1984). The
solubilized vesicle fractions were resolved on 5-20% su-
crose gradients prepared in the corresponding detergent.
Three sedimentation times were selected to facilitate analy-
sis of material with a wide range of sedimentation velocities.
Fractions from each gradient (including the pellet) were ex-
amined by SDS-PAGE and Western blotting for the presence
of the following synaptic vesicle markers: SV2, p65, p38,
H+ 39 kD, rab3A, and VAMP The results of such an ex-
periment are presented in Fig. 2 . Interactions involving the
synaptic vesicle proteins would be expected to result in
cosedimentation oftwo or more markers on a single gradient
(Fig. 2, a-c) and/or differences in the sedimentation be-
havior of a single marker among the different detergents
(Fig. 2, d-i ). The relevant observations derived from Fig.
2 have been classifiedby detergent and are described below.
CHAPS. The sedimentation behavior of the CHAPS-
solubilized synaptic vesicle proteins is presented in Fig. 2 a .
The presence of a large protein complex was suggested by
the rapid sedimentation of SV2, p65, p38, H+ 39 kD, and
VAMP. A portion ofeach ofthese proteins migrated well into
the gradient after 1.5 h of sedimentation, away from the
majority of protein (not shown), and was recovered in the
pellet after 5 h of sedimentation. Of the proteins examined,
only rab3A was excluded from the complex. This rapidly
sedimenting complex was not observed in either octylgluco-
side- (Fig. 2 b) or Triton X-100-solubilized vesicle prepara-
tions (Fig. 2 c). This difference among the three detergents
is exemplified by the distribution of p38 after 1.5 h of sedi-
mentation (Fig. 2 d), and of the H+ 39 kD after 5 h of sedi-
mentation (Fig. 2 f). Another component of the vacuolar
proton pump, the 115-kD accessory subunit, displayed sedi-
mentation properties identical to the H+ 39 kD (not shown),
suggesting. that the observed differences among the deter-
gents were not the result ofdisruption of the multimericpro-
ton pump complex.
The sedimentation behavior ofthe fraction of each synap-
tic vesicle protein not included in the large complex was also
of interest. Cosedimentation of the p65 and SV2 remaining
in the gradient (especially the lowerband ofthe SV2 doublet)
was apparent at the 5-h timepoint (Fig. 2 a) . A comparison
of the p65 distribution among the three detergents after 5 h
of sedimentation (Fig. 2 e) revealed that the CHAPS-
solubilized p65 sedimented most rapidly, again suggesting
that an interaction involving p65, distinct from the large
complex, was preferentially preserved by CHAPS. After
16 h of sedimentation of the CHAPS-solubilized vesicles
(Fig. 2 a), most of the SV2, p65, and H+ 39 kD were recov-
ered in the pellet. The markers remaining in the gradient
were resolved as independent species with relative sedimen-
764Figure 2 . Sucrose gradient analysis of detergent-solubilized synaptic vesicles . Synaptic vesicle fractions were solubilized in CHAPS (a),
octylglucoside (b), or Triton X-100 (c) and resolved on 5-20% linear sucrose gradients prepared in the corresponding detergent (as de-
scribed in Materials and Methods) . Fractions from the gradients (starting from the top, fraction 1, through the pellet, P) were collected
and analyzed by Western blotting for the presence of SV2, p65, p38, H+ 39 kD, rab3A, andVAMP Panels d-i highlight differences among
the three detergents for a single marker and timepoint : d, p38 at 1.5 h ; e, p65 at 5 h ; f, H+ 39 kD at 5 h ; g, p38 at 16 h; h, rab3A at
16 h ; and i, VAMP at 16 h . The sedimentation behavior ofprotein standards was determined on parallel gradients . After 1.5 hofsedimenta-
tion, apoferritin (17.6S) was recovered in fraction 3 and catalase (11 .3S) in fraction 2 . After 5 h of sedimentation, catalase was recovered
in fraction 5 and ovalbumin (3.5S) in fraction 2 . After 16 h of sedimentation ovalbumin was recovered in fraction 5 and cytochrome c
(1.75S) in fraction 3.
tation rates of p38 > rab3A > VAMP The sedimentation
of p38 on these gradients was the same as that previously
described for a p38 homooligomer (120 kD ; Rehm et al .,
1986) .
Octylglucoside. The sedimentation behavior of the octyl-
glucoside-solubilized synaptic vesicle proteins is presented
in Fig . 2 b . After 1.5 h of sedimentation only SV2 migrated
well into the gradient . By 5 h of sedimentation a large por-
tion ofSV2 was recovered in the pellet, and that which re-
mained in thegradient was well resolved fromp65, in contrast
to the cosedimentation observed with CHAPS-solubilized
vesicles . A portion of rab3A, but no other synaptic vesicle
marker tested, sedimented as rapidly as SV2 following octyl-
glucoside solubilization (Fig . 2 b) . Additional differences
among the three detergents were observed after 16 h of sedi-
mentation . A portion ofboth p38 (Fig . 2 g) and rab3A (Fig . 2
h) sedimented more rapidly in the octylglucoside-solubilized
sample than in the CHAPS- or Triton X-100-solubilized
samples . This suggests that octylglucoside may at least par-
tially preservesomeinteractions involving these twoproteins .
Triton X-100 . The sedimentationbehavior ofTritonX-100-
solubilized synaptic vesicle proteins is presented in Fig . 2 c .
Co-sedimentation of p65 and SV2 was observed at both the
5- and 16-h timepoints . This co-sedimentation occurred at
a slower rate than the cosedimentation ofthe same two mark-
ers in the CHAPS-solubilized sample (Fig . 2 a) . In addition,
cosedimentation of p38 and VAMP was apparent in the Tri-
ton X-100-solubilized sample (Fig . 2 c) . The resulting shift
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in the distribution ofVAMP was most clearly seen after 16 h
of sedimentation (Fig. 2 i) .
The results of the sucrose gradient sedimentation analysis
indicate that a number of interactions may occur between
different synaptic vesicle proteins, and that these interactions
may be differentially preserved by the detergents used in this
study. However, several problems exist in the interpretation
ofthese sedimentation results . One problem is that some in-
teractionsmay be unstable under the conditions of sedimen-
tation : high centrifugal force, high sucrose concentration,
and long sedimentation times . These factors could result in
partially overlapping sedimentation distributions, or spread-
ing of markers across the gradient as weak interactions are
disrupted during sedimentation (Fig . 2) . In addition, the
sedimentation behavior ofmembrane proteins is influenced
by the amount and type ofdetergent bound (Tanford and Rey-
nolds, 1976) . Some of the sedimentation differences among
the three detergentsmay reflect this fact . Finally, it is difficult
on the basis of sedimentation behavior alone to determine if
the observed differences in sedimentation result from hetero-
philic or homophilic interactions, or both . To further define
the interactions between synaptic vesicle proteins, we per-
formed immunoprecipitation experiments .
Immunoprecipitation
The results of an immunoprecipitation experiment are pre-
sented in Fig . 3. As with the sedimentation analysis, vesi-
765Figure3 . Immunoprecipitation analysis of detergent-solubilized synaptic vesicles . Solubilized synaptic vesicle proteins were subjected to
immunoprecipitation (as described in Materials andMethods) with the following antibodies : lane a, 6F2 (control) ; lane b, anti-p65 ; lane
c, anti-SV2 ; lane d, anti-p38 ; and lane e, antiVAMP. The immunoprecipitates were analyzed by Western blotting for the presence ofSV2,
p65, p38, H+ 39 kD, rab3A, VAMP, and the a subunit of the Nat/K' ATPase (a), and by silver staining (b) . Lane T (total) corresponds
to 1/10th of the starting sample used for the immunoprecipitations, while the "no lysate" panels display the background contributed by
the antibody protein A-Sepharose bead complexes . In b, the positions of the molecular weight standards, p65, p38, H+ 39 kD, VAMP,
four proteins enriched in the anti-p65 precipitates (ti-iv), BSA, and the IgG heavy and light chains are indicated .
cle fractions were solubilized inCHAPS, octylglucoside, or
Triton X-100 . Immunoprecipitations were performed using
antibodies against four synaptic vesicle proteins (p65, b
lanes ; SV2, clanes ; p38,dlanes ; andVAMP, elanes) as well
as a control mAb directed against Aplysia-dense core gran-
ules (a lanes) . The immunoprecipitates were resolved on
three identical 12% polyacrylamide gels . Two gels were
transferred to nitrocellulose for Western blot analysis (Fig.
3 a), and the third gel was silver stained to reveal total pro-
tein patterns (Fig . 3 b) . The Western blots were probed for
the presence ofsixsynaptic vesicle proteins (SV2, p65, p38,
H+ 39 kD, rab3A, and VAMP) as well as a plasma mem-
brane marker (the a subunit of the Na+/K+ ATPase) . The
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Na+/K+ ATPase is a contaminant in the vesicle preparation
and serves as an internal control for nonspecific aggregation
and/or trapping ofmembrane proteins . A sample ofthe anti-
body/beadcomplex that was not exposed to solubilized syn-
aptic vesicles was also run on the gels to determine the
background contributed by the antibody alone ("no lysate"
panels) . To determine the relative recovery of each marker,
a sample of the starting vesicle fraction (corresponding to
10% ofthe material used for each immunoprecipitation) was
also analyzed (lane T) . The results described below have
been divided into observations regarding the background,
specific observations concerning each solubilizing deter-
gent, and observations derived from the silver stained gel .
766Background. The background signal contributed by anti-
body alone on Western blots (Fig. 3 a, no lysate) was re-
stricted to lanes d and e (where whole rabbit sera were used
for the immunoprecipitation). In these lanes a small amount
of background on the strips corresponding to H+ 39 kD,
rab3A, and Na+/K+ ATPase was detected. The background
contributed by antibody alone to the silver-stained protein
pattern (Fig. 3 b, "no lysate" panel) consisted of the predomi-
nant heavy and lightchains of the IgG's as well as several mi-
nor bands which varied among the antibody preparations.
Under all three detergent conditions used, very little non-
specific binding to the control antibody/protein A-Sepharose
complex was detected by either Western blotting (Fig. 3 a,
a lanes) or silver staining (Fig. 3 b, a lanes).
CHAPS. Antibodies directed against four different synap-
tic vesicle proteins (p65, SV2, p38, and VAMP) were each
capable of immunoprecipitating five synaptic vesicle mark-
ers (SV2, p65, p38, H+ 39 kD, and VAMP) from a CHAPS-
solubilized vesicle fraction (Fig. 3 a, CHAPS, lanes b-e) . A
sixth vesicle marker (rab3A) was not precipitated. This re-
sult is consistent with the observed cosedimentationof SV2,
p65, p38, H+ 39 kD, and VAMP as a large complex in
CHAPS-solubilized preparations (Fig. 2 a). The immuno-
precipitation efficiency of the different markers, by compari-
son with the starting fraction (Fig. 3 a, lane T), was variable.
For example, anti-p65 (lane b) efficiently precipitated p65,
SV2, H+ 39 kD, and VAMP, but precipitated p38 with a
lower efficiency. Similarly, anti-p38 was efficient at precipi-
tating p38 and VAMP, but relatively inefficient at precipitat-
ing SV2 and p65. This variability may reflect the possibility
thatdifferent fractions ofaparticularmarker are foundassoci-
ated withthe large complex. Alternatively, variable immuno-
precipitation efficiency may be the result of epitope inacces-
sibility or destabilizationofinteractions by antibody binding.
In spiteof the variable immunoprecipitation efficiency, three
lines of evidence indicate that the coprecipitation ofmultiple
markers from CHAPS-solubilized vesicles is specific. First,
very little of either the Na+/K+ ATPase or rab3A present in
the starting material was recovered in the immunoprecipi-
tates (Fig. 3 a, compare lane T with CHAPS, lanes b-e).
Second, immunoprecipitations of octylglucoside- or Triton
X-100-solubilized vesicles resulted in coprecipitations of
some markers (see below), but not all five markers simul-
taneously as in CHAPS (Fig. 3 a) . Finally, the total protein
patterns of the immunoprecipitates were much simpler than
that of the starting fraction (Fig. 3 b), suggesting that non-
specific aggregation or trapping was not occurring.
Octylglucoside. Solubilization of vesicles with octylgluco-
side followed by immunoprecipitation with anti-p65 (Fig. 3
a, octylglucoside, lane b) resulted in the recovery of p65 and
a small amount of SV2 (much less than the recovery in
CHAPS or Triton X-100) . None ofthe other immunoprecipi-
tations resulted in significant recovery of p65. Similarly,
antiVAMP (lane e) was capable ofprecipitating only VAMP,
and VAMP was not precipitated by any of the other antibod-
ies. These results suggest that p65 and VAMP are, for the
most part, independent of the other markers tested. Very
different results were obtained with anti-SV2 (lane c) and
anti-p38 (lane d). Both of these antibodies were capable of
coprecipitating SV2, p38, and a portion of rab3A from octyl-
glucoside-solubilized vesicles. This observation supports the
sedimentation result which suggested that interactions in-
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volving rab3A and p38 were preferentially preserved follow-
ing octylglucoside solubilization (Fig. 2, g and h) . The same
arguments concerning specificity made above for the CHAPS-
solubilized samples also apply to the octylglucoside-solubil-
ized samples with one notable exception. A significantamount
of the Na+/K+ ATPase was recovered in the anti-SV2 pre-
cipitate (Fig. 3 b, octylglucoside, lane c). This was the only
antibody/detergent combination that resulted in co-precipi-
tation of the plasma membrane marker. The total protein
pattern corresponding to this immunoprecipitate (Fig. 3 b,
octylglucoside, lane c) did not display a high background in-
dicative of nonspecific aggregation or trapping. This raises
the possibility that the recovery of the Na+/K+ ATPase un-
der these conditions is specific (see Discussion).
Triton X-100. Solubilization of vesicles with Triton X-100
followed by immunoprecipitation with anti-p65 (Fig. 3 a,
Triton X-100, lane b) resulted in efficient recovery ofp65 and
SV2, and less efficient recovery of H+ 39kD and VAMP
Immunoprecipitation with anti-SV2 (lane c) resulted in
efficient recovery of SV2 and less efficient recovery of p65.
These results support the potential interaction involving p65
and SV2 suggested by their cosedimentation following Tri-
ton X-100 solubilization (Fig. 2 c) . Immunoprecipitation of
Triton X-100-solubilized sample with either anti-p38 (lane
d) or antiVAMP (lane e) resulted in recovery of both p38
and VAMP This result is again in support of the sedimenta-
tion results following Triton X-100 solubilization suggestive
of an interaction involving p38 and VAMP (Fig. 2 c) .
Silver Staining. Several of the synaptic vesicle proteins
(p65, p38, H+ 39 kD, and VAMP) were clearly detected in
the immunoprecipitates by silver staining (Fig. 3 b). In addi-
tion to the known synaptic vesicle proteins, several uniden-
tified proteins were recovered in the immunoprecipitates.
Most of these proteins were detected only with particular an-
tibody/detergent combinations and often did not correlate
with abundant proteins in the starting fraction. Proteins
marked with asterisks (Fig. 3 b, i-iv) were particularly well
recovered in anti-p65 precipitates under all three solubiliza-
tion conditions. Band i is a doublet of35 kD that is not abun-
dant in the starting fraction. Band ii (29 kD) co-migrates
with an abundant protein in the starting fraction and is the
same size as a known synaptic vesicle protein (p29 ; Baumert
et al., 1990). Band iii is a heterogeneous protein, or set of
proteins, in the 20-kD region that is not abundant in the start-
ing fraction. Band iv (16 kD) runs at a position that corre-
sponds to a protein in the starting vesicle fraction that par-
titions into the organic phase upon chloroform/methanol
extraction, and thus may be the proteolipid subunit (subunit
c in Fig. 1) of the proton pump (Mandel et al., 1988). The
nature of these and other coprecipitating proteins will be the
topic of future studies.
Comparison ofthe MultimericProtein Complex with
Intact Synaptic Vesicles
To compare the protein and lipid composition of intact syn-
aptic vesicles with that of the multimeric complex recovered
after CHAPS solubilization, anti-p65 immunoprecipitations
ofsalt-washed (intact) and CHAPS-solubilized vesicles were
performed . The samples were analyzed for protein composi-
tion by SDS/PAGE (Fig. 4 a) and for lipid composition by
TLC (Fig. 4 b). The protein composition of intact vesicles
767(Fig . 4 a, lane 2) was very similar to the multimeric complex
(Fig . 4 a, lane 3), and both were highly simplified as com-
pared to the starting fraction (Fig . 4 a, lane 1) . The major
proteins detected in intact vesicles were p65, p38, H+
39kD, and VAMP, consistent with published results (Floor
and Leeman, 1988 ; Burger et al ., 1989) . Peripheral synaptic
vesicle membrane proteins (including synapsin I and the
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Figure 4. Comparison of in-
tact vesicles with the CHAPS-
solubilized protein complex .
Synaptic vesicles were treated
with0.5MNaClor2%CHAPS
and subjected to immunopre-
cipitation with anti-p65. The
starting LP2 fraction (lanes 1),
intact vesicles (lanes 2), and
the CHAPS-solubilized pro-
tein complex (lanes 3) were
analyzed for protein composi-
tion by SDS-PAGE followed
by Coomassiebluestaining (a)
and for lipid composition by
TLC (b) as described in Ma-
terials and Methods. In a,
the positions of the molecular
weight standards, p65, p38,
H+ 39 kD, VAMP, two pro-
teins enriched in theCHAPS-
solubilized protein complex
(*), BSA, and the IgG heavy
and light chains are indicated .
In b, the positions of phos-
phatidylethanolamine (PE),
phosphatidylserine (PS), phos-
phatidylcholine (PC), sphingo-
myelin (SM), andCHAPS are
indicated . The material mi-
grating at the solvent front
consisted of nonpolar lipids
andanunidentified component
derived from the extraction
procedure .
catalytic subunits of the proton pump) were not recovered in
either the intact vesicles or the multimeric complex . The rel-
ative amounts of the known synaptic vesicle membrane pro-
teins were determined by densitometry. The approximate
molar ratio of p65:p38:H+ 39 kD:VAMP was 1.0/0.72/0.66/
1.6 in intact synaptic vesicles and 1.0/0.13/0.36/0.55 in the
CHAPS-solubilized protein complex . This difference in the
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Figure S . Reconstitution of
vesicle protein interactions .
Synaptic vesicle fractions were
solubilized inCHAPS (lanea),
octylglucoside (lane b), or oc-
tylglucoside followed by de-
tergent exchange by dialysis
againstCHAPS (lane c) as de-
scribed in Materials and Meth-
ods. Proteins interacting with
p65 were detected by immuno-
precipitation and Western blot
analysis. Lane T (total) corre-
sponds to 1/10th ofthe starting
sample used for each solubil-
ization .
ratios indicates that different fractions of each vesicle protein
are associated with the multimeric complex . The recovery
of p65 was higher in the CHAPS-solubilized protein com-
plex than in the intact vesicles, suggesting that the epitope
is more accessible following detergent solubilization . Two
unidentified proteins (marked with asterisks) were enriched
in the CHAPS-solubilized complex, and may correspond to
proteins i and ii identified in Fig . 3 b. The lipid composition
of intact synaptic vesicles consisted of predominantly phos-
pholipids (Fig . 4 b, lane 2) and cholesterol (not shown), and
lacked several of the lipids detected in the starting fraction
(Fig . 4 b, lane 1) . The CHAPS-solubilized protein complex
contained no detectable phospholipid (Fig . 4 b,lane 3) or
nonpolar lipids (not shown) despite high levels of several
synaptic vesicle proteins (Fig . 4 a) . The only spots detectable
on theTLC plate were attributable to the presence ofCHAPS
in the lipid extract . These results demonstrate that the com-
plex of synaptic vesicle proteins recovered after CHAPS
solubilization includes a large fraction ofthe constituent pro-
teins and very little, if any, lipid .
Reconstitution ofthe Vesicle Protein Complex
The results of both sedimentation and immunoprecipitation
experiments on CHAPS-solubilized vesicles suggest the
presence of a large complex of synaptic vesicle proteins that
includes SV2, p65, p38, H+ 39 kD, and VAMP To better
understand the nature of the interactions involved in this pro-
tein complex, a reconstitution experiment was done (Fig. 5) .
Vesicles were solubilized in octylglucoside and the octyl-
glucoside then exchanged for CHAPS by dialysis . Todeter-
mine the extent to which interactions that were disrupted by
octylglucoside could be restored, the dialyzed sample was
subjected to immunoprecipitation with anti-p65 (lane c) . For
comparison, anti-p65 immunoprecipitations were also per-
formed on vesicles directly solubilized in CHAPS (lane a)
or in octylglucoside (lane b) . The immunoprecipitates were
analyzed by Western blotting for the presence of SV2, p65,
p38, H+ 39 kD, and VAMP As previously observed, anti-
p65 precipitated p65, SV2, p38, H+ 39 kD, and VAMP
from CHAPS-solubilized vesicles, but only p65 and a re-
duced amount ofSV2 from octylglucoside-solubilized vesi-
cles . After replacement of the octylglucoside with CHAPS,
three of the synaptic vesicle proteins (p38, H+ 39 kD, and
VAMP) were again recovered by anti-p65 precipitation . SV2
did not reassociate under these conditions . The Na+/K+ ATP-
ase was not precipitated under any of these conditions (not
shown) . These results suggest that the interactions among
some of the synaptic vesicle proteins can be disrupted and
subsequently reconstituted, implying that specific binding or
association is involved . Additional experiments (not shown)
demonstrated that the vesicle protein complex immunopre-
cipitated by anti-p65 from a CHAPS-solubilized sample was
stable when treated with high salt (1 M potassium acetate),
reducing agent (100 mM DTT), CaCl2 (2 mM), or cholate
(1%), but was disrupted by Zwittergent 3-10 (2%) or SDS
(0.1%) .
Gel Filtration Chromatography
To further characterize the synaptic vesicle protein complex
observed following CHAPS solubilization, a combined size
fractionation and immunoprecipitation analysis was per-
formed . A vesicle fraction solubilized in CHAPS was
resolved on a Biogel A-5m gel filtration column equilibrated
with 1% CHAPS . Alternate fractions across the column
were analyzed by Western blotting (Fig . 6 a) . A portion of
SV2, p65, p38, H+ 39 kD, and VAMP was recovered in a
peak just after the void volume (fractions 19-23), again sug-
gestive of a large complex (see also Fig . 7 b) . The re-
mainders of these markers were resolved over the rest of the
column fractions . rab3A eluted as a single well-included
peak . The coelution of the five synaptic vesicle proteins near
the void volume was not observed with vesicles solubilized
in other detergents. In octylglucoside, only SV2 eluted in the
region of the void volume ; in Triton X-100, none ofthe mark-
ers tested eluted near the void volume (not shown) . A portion
of the Na+/K+ ATPase was also recovered in the void region
(Fig . 6 a), but this behavior was independent ofthe detergent
used for solubilization (not shown) . Three separate pools
were prepared from different column elution positions (pool
I, fractions 18 and 20 ; pool II, fractions 24 and 26 ; and pool
III, fractions 30 and 32) for subsequent immunoprecipitation
analysis (Fig. 6 b) . Immunoprecipitation of pools I and II
with anti-p65 and anti-SV2 resulted in coprecipitation of
p65, SV2, p38, H+ 39 kD, and VAMP, suggesting that the
multicomponent complex is not exclusively localized to the
largest elution position, but rather is spread over a wide
range of sizes . Immunoprecipitation of pool III with anti-
SV2 resulted in recovery of SV2, p65, and a small amount
of VAMP Immunoprecipitation of pool III with anti-p38
resulted in recovery of p38 and a small amount of VAMP
These results suggest that the material eluting in the later
fractions from the gel filtration column is made up of both
subcomplexes (SV2-p65 and p38VAMP) and species that are
independent of other markers (rab3A) .
The fact that CHAPS-solubilized vesicle proteins can be
resolved into complexes with differing sizes and composi-
tions suggests that at least some of the interactions involved
in the large multicomponent complex are unstable . In addi-
tion, the differential effects of detergents on the vesicle pro-
tein interactions and the resistance of the multicomponent
complex to high salt suggest thatsome ofthe interactions in-
volved are hydrophobic in nature . To determine if the puta-
tive weak hydrophobic interactions could be stabilized by
reducing the detergent concentration, a vesicle fraction was
solubilized in 2% CHAPS and resolved on a Biogel A-5m
column equilibrated with 0.25% CHAPS (below the critical
micelle concentration of CHAPS) . As seen in Fig . 7 a, a
769Figure 6. Gel filtration analysis of CHAPS-solubilized synaptic
vesicles . A synaptic vesicle fraction was solubilized inCHAPS and
resolved on a BioGel A-5m column in the presence of 1% CHAPS
as described in Materials and Methods . Alternate fractions were
analyzed by Western blotting for SV2, p65, p38, H+ 39 kD, rab3A,
VAMP, and the a subunit of the Na`/K+ ATPase (a) . Three pairs
of fractions (marked I, II, and III in a) were separately pooled and
analyzed by immunoprecipitation and Western blot analysis b) . Vo
and V, correspond to the void and total volumes of the column,
respectively.
striking redistribution of five of the markers occurred when
the detergent concentration was lowered . Quantitation of the
column profiles ofeach vesicle marker under high (Fig . 6 a)
and low (Fig . 7 a) CHAPS conditions is presented in Fig .
7 b. At low CHAPS concentration, SV2, p65, and H+ 39
kD were recovered almost exclusively in the void region, and
much larger fractions of both p38 and VAMP coeluted with
this large complex . The distribution of rab3A and Na+/K+
ATPase remained unchanged, suggesting that the observed
differences were not the result of nonspecific aggregation of
membraneproteins . In addition, two enzymatic activities as-
sociated with synaptic vesicles, an N-ethylmaleimide-sensi-
tive ATPase (Yamagata and Parsons, 1989) and a ceramide
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Figure 7 . Reformation of the large vesicle protein complex by gel
filtration . A synaptic vesicle fraction was solubilized in CHAPS
and resolved on a BioGel A-5m column in the presence of 0.25%
CHAPS . Alternate fractions were analyzed by Western blotting for
SV2, p65, p38, H+ 39 kD, rab3A, VAMP, and the a subunit of the
Na+/K+ ATPase (a) . Quantitation of the column profiles (b) for
each synaptic vesicle marker in 1% CHAPS (-----, from Fig . 6 a)
and 0.25% CHAPS (-, from Fig . 7 a) . Va and Vt correspond to
the void and total volumes of the column, respectively.
kinase (Bajjalieh et al ., 1989), were recovered near the void
volume in low detergent concentrations (M . K . Bennett and
S . Bajjalieh, unpublished observation) . The fact that these
markers retained enzymatic activity suggests that their na-
tive structures were preserved . The redistribution of the syn-
aptic vesicle markers was not associated with a dramatic
change in the overall protein profile across the column frac-
tions (not shown), further indicating that the interactions
leading to complex reformation are specific . In addition, the
large complex recovered at lowCHAPS concentration could
be disrupted by subsequent treatment with Triton X-100.
These observations suggest that specific interactions among
5 synaptic vesicle markers (SV2, p65, p38, H+ 39 kD, and
VAMP) can be promoted or stabilized by lowering the deter-
770gent concentration, supporting the possibility that some of
the interactions are hydrophobic in nature .
Electron Microscopy
The morphology of the large complex of synaptic vesicle
proteins was examined by transmission EM . A sample of
CHAPS-solubilized vesicles was resolved on a BioGelA-5m
column in the presence of 1% CHAPS. Fractions eluting
near the void volume (corresponding to pool I in Fig . 6 a)
were pooled and observed after negative staining with uranyl
acetate (Fig . 8 a) . The structures were variable in appear-
ance, but they often consisted of two or more globular do-
mains with either circular (N25-nm diam) or elongated (ti10
x 35 nm) morphology. To determine which structures in-
clude the vesicle proteins, a CHAPS-solubilized vesicle
fraction was incubated with either gold-conjugated anti-p65
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Figure 8 . Negative stain EM
of the synaptic vesicle pro-
teincomplex. Synaptic vesicle
fractions were solubilized in
CHAPS and incubated either
with no antibody (a), 8-nm
gold-conjugated anti-p65 (b),
8-tun gold-conjugated anti-
p65 and 20-nm gold-conju-
gated anti-SV2 (c), or 8-nm
gold-conjugated anti-p65 in
the presence of excess unla-
beled anti-p65 (d) . In each
case, the large synaptic vesicle
protein complex was isolated
by gel filtration chromatogra-
phy and analyzed by nega-
tive stain EM as described in
Materials and Methods . Bar,
50 run .
(8 nm gold ; Fig . 8 b) or gold-conjugated anti-p65 and gold-
conjugated anti-SV2 (20 nm gold ; Fig . 8 c) before gel filtra-
tion chromatography . The gold-labeled structures eluting
near the void volume were similar to the structures recovered
in the absence of antibody (Fig . 8 a) . The gold-conjugated
anti-p65 was always found in clusters that were associated
with one ofthe globular domains (Fig . 8 b) . Since each gold
particle is coupled to multiple antibody molecules, the fact
that an average of five gold particles were associated with
each structure suggests that the complex contains multiple
copies of p65. In the structures labeled with both gold-
conjugated antibodies (Fig. 8 c), the anti-SV2 often labeled
a limited domain of the structure, and the structures were
less well defined, perhaps due to perturbation by antibody
binding . The specificity of labeling was demonstrated by the
lack of gold particles in samples that were prepared in the
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Figure 9 . Schematic represen-
tation of interactions between
synaptic vesicle proteins fol-
lowing detergent solubiliza-
tion. Shaded objects indicate
interactingproteinswhilenon-
shaded objects represent pro-
teins that are independent of
other markers . The thickness
of the lines connecting the
proteins indicates the relative
"strength" of the interactions.
For details see Discussion .
presence of excess unlabeled anti-p65 (Fig . 8 d) . The fact
that similar structures were observed in all four conditions
suggests that antibody-induced cross-linking is not occur-
ring . When anti-p65-labeled complex was isolated (as in
Fig. 8 b), embedded in epon, and observed in thin sections,
clusters of gold were again seen, but the structures were
poorly preserved (not shown), indicating the absence of a
high density of protein or lipid .
We have identified a number ofinteractions involving synap-
tic vesiclemembrane proteins which are preserved following
detergent solubilization . These interactions are summarized
in Fig . 9 . The lines connecting the interacting proteins
(shadedobjects) indicate the efficiency with which the differ-
ent proteins co-isolate during fractionation . Thick lines indi-
cate the most efficient or strongestinteractions, and thinlines
the least efficient . Apparent weak interactions could be the
result of either unstable or low affinity binding between the
components, or the participation of only subpopulations of
the proteins in the interaction . The positions of the vesicle
proteins in Fig . 9 were conserved among the three detergents
so that the diagram may depict the relative position of each
marker present in a native lipid environment. The interac-
tions depicted are not necessarily direct, since other compo-
nents of the synaptic vesicle protein complexes could be in-
volved . The precise nature ofthe interactions, the amount of
each marker involved, and the possible regulation of the in-
teractions remain to be determined .
The complex of proteins preserved in CHAPS (Fig . 9 a)
includes all of the markers tested except rab3A, but no de-
tectable lipid . Sucrose gradient and gel filtration analysis in-
dicated that the multicomponent complex was heterogeneous
in size. In addition, some of the markers were recovered in
subcomplexes (or not included in any complex) following
CHAPS solubilization . These results suggest that the largest
complexes may be unstable under the conditions used for
isolation . The large complex of synaptic vesicle proteins ap-
peared by negative stain electron microscopy to be com-
posed oftwo or more globular domains and could be labeled
The Joumal of Cell Biology, Volume 116, 1992
with gold-conjugated antibodies against SV2 and p65 (Fig .
8) . Both p65 and SV2 appeared to label limited domains of
the observed structures . The other domains are likely to con-
sist of the multimeric proton pump complex and/or oligo-
mers of p38 (Thomas et al ., 1988) .
In contrast to the large multicomponent complex recov-
ered inCHAPS, smaller complexes of synaptic vesicle mem-
brane proteins were recovered following solubilization in oc-
tylglucoside and Triton X-100. In octylglucoside (Fig . 9 b)
a complex ofSV2, p38, and rab3A was detected by immuno-
precipitation . Immunoprecipitation of octylglucoside solu-
bilized vesicles with anti-SV2 also resulted in the specific
recovery of a small amount of plasma membrane Na+/K+
ATPase. It is known that the Na+/K+ ATPase interacts with
submembranous cytoskeletal components, including anky-
rin and fodrin (Nelson and Hammerton, 1989) . Electron mi-
croscopic evidence has indicated that fodrin may play a role
in the anchoring of synaptic vesicles near the presynaptic
membrane (Hirokawa et al., 1989) . In addition, fodrin can
regulate the fusion of chromaffin granules with the plasma
membrane (Perrin et al., 1987) . Perhaps the putative inter-
action involving SV2 and the Na+/K+ ATPase reflects an in-
teraction ofthe synaptic vesicles with the fodrin cytoskeleton
before exocytosis . Such an interaction between SV2 and
cytoskeletal components might also explain the large size of
the octylglucoside-solubilized SV2 detected on sucrose gra-
dients . Distinct from the interactions in octylglucoside were
two interactions preserved following Triton X-100 solubili-
zation of synaptic vesicles (Fig . 9 c) . One interaction in-
volved predominantly SV2 and p65, with small amounts of
VAMP and the proton pump, while the other involved p38
and VAMP.
In addition to the known synaptic vesicle proteins, several
otherproteins (as detected by silver staining) were recovered
by inununoprecipitation of solubilized vesicle fractions . It
will be of interest to characterize these proteins further to
see ifthey represent novel synaptic vesicle specific proteins,
or if they represent soluble, cytoskeletal, or nonvesicular
membrane proteins that might specifically interact with the
synaptic vesicle proteins at some point in their lifecycle .
To determine the proportion of vesicular protein present
in the large complex, and to establish the number of com-
plexes that might exist in a single vesicle, an estimate of the
amount of protein/vesicle is required . The most detailed
physical characterization of a synaptic vesicle preparation
was carried out by Wagner et al . (1978) on vesicles isolated
from the electric organ of Narcine brasiliensis . These -80-
nm-diam vesicles had a buoyant density of 1.05 g/ml and a
protein to lipid ratio of 1 :5. Based on these and other values
it was estimated that each vesicle contains -6.4 x 106 dal-
tons ofprotein . Extrapolation ofthese values to 40-nm-diam
mammalian synaptic vesicles yields -1.6 x 106 daltons of
protein/vesicle. However, mammalian synaptic vesicles have
a higher buoyantdensity than electric fish vesicles (1.12 g/ml ;
Floor et al ., 1988 ; Clift-O'Grady et al ., 1990 ; Cutler and
Cramer, 1990), suggesting that they have a higher protein to
lipid ratio. If one assumes a protein to lipid ratio of 1 :1 for
mammalian synaptic vesicles, then the protein content would
be -4 x 106 daltons/vesicle . Floor et al . (1990) have esti-
mated the abundance of the vacuolar proton pump in rat
brain synaptic vesicles to be -20% of total vesicular pro-
tein . They suggest that there are six protonpump complexes
772(ti500 kD each) on a single vesicle. These estimates yield
a value of 15 x 106 daltons of protein/vesicle. Based on
these data, it is reasonable to assume that a mammalian syn-
aptic vesicle contains on the order of 4-15 x 106 daltons of
protein. The largest complex of synaptic vesicle proteins
preserved in CHAPS had a relative sedimentation coefficient
ofgreater than 20S, and eluted near the void volume on a gel
filtration column with an exclusion limit of 5 x 106 dal-
tons. These values suggest that a large proportionof the total
vesicular protein is participating in the complex, consistent
with the protein composition of the multimeric complex
(Fig. 4a), and that the number ofcomplexes/vesicle is three
or less. The apparent size of the synaptic vesicle protein
complex, as observed by negative stain EM, would occupy
a significant portion of the synaptic vesicle surface, consis-
tent with these estimates . The complex of vesicle proteins
may represent a tight cluster of proteins within a restricted
domain of the vesicle membrane, or a loose-knit "scaffold"
spread over the vesicle surface; this remains to be estab-
lished. Consistent with our results is a report that treatment
of synaptic vesicles with a chemical cross-linking reagent
resulted in the formation of a cross-linked complex (ti5 x
106 daltons) that included most of the synaptic vesicle pro-
tein (Zisapel, 1982).
The functions of synaptic vesicle proteins are likely to in-
clude intracellular targetting, recognition of and fusion with
the plasma membrane, and endocytic recycling to regenerate
synaptic vesicles (Siidhof and Jahn, 1991) . The interactions
between synaptic vesicle proteins we observe have a number
of implications with regard to these functions. Sorting and
targetting of synaptic vesicle proteins is likely to occur both
at the trans-Golgi network during biogenesis and at the
plasma membrane and/or early endosome during recycling.
Little is known about the molecular signals which govern the
targetting of synaptic vesicle proteins. There is no indication
of a consensus targetting signal from the primary sequences
of synaptic vesicle proteins cloned to date. The putative tar-
getting signal may be represented by a common secondary
or tertiary structure, as with the signal for mannose phos-
phorylation of lysosomal hydrolases (Baranski et al., 1990).
In this case, no common primary sequence would be detect-
able. Recent experiments in which p38 was expressed in non-
neuronal cells indicate that this protein is targetted to en-
docytic vesicles (Leube et al., 1989; Johnson et al., 1989;
Linstedt and Kelly, 1991) . This result suggests that p38 con-
tains some targetting information. One possibility that is
raised by our results is that targetting, both during synaptic
vesicle biogenesis and during endocytic recycling, is medi-
ated by a single vesicle protein with primary targetting infor-
mation. Other vesicle proteins could be targetted by virtue
of interactions with this protein. p38 is a good candidate for
such a targetting protein, given its localization following ex-
pression in non-neuronal cells, and its apparent interactions
with other synaptic vesicle proteins (Fig. 9).
Another important aspect of synaptic vesicle protein func-
tion is the process of docking and fusion. A population of
synaptic vesicles is closely associated with the presynaptic
plasma membrane. These vesicles fuse very rapidly after
Cal' influx, suggesting that the cellular machinery required
for membrane fusion is already assembled. The molecular
mechanisms involved in cellular membrane fusion events are
Bennett et al. Synaptic Vesicle Protein Complex
not well defined. Studies of secretory mutants in yeast and
the use of cell-free assays for transport vesicle fusion have
led to the identification of a number of factors that are re-
quired for membrane fusion (Wattenberg and Rothman,
1986; Malhotra et al ., 1988; Eakle et al., 1988; Weidman
et al ., 1989; Clary et al., 1990; Goda and Pfeffer, 1991).
Several of these factors appear to be soluble or peripheral
membrane components that assemble into a pre-fusion com-
plex. It is possible that some of the interactions observed be-
tween the different synaptic vesicle proteins represent inte-
gral membrane constituents of such a pre-fusion complex. It
will be of interest to determine if any of the other proteins
in the synaptic vesicle protein complexes are related to the
proteins proposed to be part of the fusion machinery in other
systems.
The large complex of vesicle proteins recovered following
CHAPS solubilization couldplay an important role in the re-
cycling of synaptic vesicle membrane proteins. The mecha-
nism by which synaptic vesicles are regenerated following
exocytosis is not well established. One model suggests that
the vesicle membrane becomes fully incorporated into the
plasma membrane and that recycling requires an endocytic
process involving coated pits, coated vesicles, and an early
endosome compartment (Heuser, 1989). Another model
proposes that exocytosis occurs by the formation of a fusion
pore, allowing vesicle contents to be released, and that recy-
cling occurs by simple closure of the fusion pore and pinch-
ing offof the vesicle (Meldolesi and Ceccarelli, 1981; Torri-
Tarelli et al ., 1987). If recycling occurs by way of a coated
vesicle pathway, the synaptic vesicle protein complex would
simplify the selection of endocytic cargo, thereby increasing
the efficiency of the process. The observations that rab3A
recycles by means of a cytosolic intermediate (Fischer von
Mollard et al., 1991), and that rab3A is excluded from the
large complex of vesicle proteins, is consistent with a role
of the large complex in endocytic recycling of integral synap-
tic vesicle membrane proteins. If exocytosis and recycling
normally occur by means of opening and closing ofa fusion
pore, the complex of vesicle proteins could play a role in
maintaining vesicle shape, preventing collapse into the
plasma membrane.
The very small size of mammalian synaptic vesicles is in-
triguing. It has been proposed that the co-expression ofmul-
tiple vesicle proteins may be required to obtain this small
size, since the vesicles that accumulate following expression
of p38 in non-neuronal cells are much larger than authentic
synaptic vesicles (Clift-O'Grady et al., 1990) . The proposed
interactions among the synaptic vesicle proteins may be
responsible for maintaining the size and shape of synaptic
vesicles, which in turn may be functionally important for the
processes of membrane fusion and recycling.
The multiple interactions between synaptic vesicle mem-
brane proteins we describe here are likely to be relevant to
several aspects of synaptic vesicle function. It will be impor-
tant to establish at which stages of the synaptic vesicle life-
cycle the various interactions occur. Equally important is the
possibility that these interactions could be the target of
regulatory mechanisms that modulate synaptic transmission.
We are now in a position to further evaluate the nature ofthe
interactions and to study their possible physiological regu-
lation .
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